Cylert

Lea en español

CylertCylert is the brand name for Pemoline, a stimulant first synthesized in 1913 and used to treat ADHD (attention deficit hyperactivity disorder) and narcolepsy. Pemoline has been pulled from the U.S. market because of reports connecting its use in children to increased risk of liver failure. After the U.S. Food and Drug Administration (FDA) issued a warning not to prescribe Pemoline for ADHD, the manufacturer and patent owner (Abbott Laboratories) stopped making Cylert.

Pemoline was first approved by the FDA in 1975. Since that date, more than 20 liver failures have been linked to the drug. Pemoline is believed to cause hepatoxicity, a chemically induced form of liver damage.

If you or someone you love has used any type of Cylert and experienced detrimental side effects, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

Defective Drugs & Medical Devices Topics

Latest Articles

Happy 4th of July

Our country is not the only thing to which we owe our allegiance. It is also owed to justice and to…

02 Jul 2020, Thursday

Supreme Court Issues Landmark LGBT Employment Law Ruling

Decision Applies Civil Rights Act to Employment Issues in All 50 States The United States Supreme Co…

25 Jun 2020, Thursday

President Seeks to Limit Liability of Meat Companies for COVID-19

Industry Continues to Be Hotspot for COVID Infection State health officials in Idaho announced on Tu…

09 Jun 2020, Tuesday